about
PET studies in epilepsyElucidation of AMPA receptor-stargazin complexes by cryo-electron microscopyAnticonvulsant Effect of Guaifenesin against Pentylenetetrazol-Induced Seizure in MiceAdenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial DisordersSeizure control by decanoic acid through direct AMPA receptor inhibitionCitrus aurantium increases seizure latency to PTZ induced seizures in zebrafish thru NMDA and mGluR's I and II.Therapeutic potential of metabotropic glutamate receptor modulators.Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications.Epilepsy-associated gene Nedd4-2 mediates neuronal activity and seizure susceptibility through AMPA receptors.NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis.Pathogenesis of epilepsy: challenges in animal modelsTranslational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.Vascular endothelial growth factor attenuates status epilepticus-induced behavioral impairments in rats.Metabotropic Glutamate Receptors and Epileptogenesis.NR2 subunit-dependence of NMDA receptor channel block by external Mg2+.Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicityDynamics of glutamatergic signaling in the mushroom body of young adult Drosophila.Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death.Effects of protopanaxatriol-ginsenoside metabolites on rat N-methyl-d-aspartic Acid receptor-mediated ion currentsNMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina.Echinacoside, an active constituent of Herba Cistanche, suppresses epileptiform activity in hippocampal CA3 pyramidal neurons.
P2860
Q26778466-58BF4DAF-6331-4B61-9464-E42D70A28114Q27715636-BD01F7C0-5223-4059-B0DA-C48A95AAD4F0Q28293894-67E3C435-52C4-44AF-AFD4-C7C365D5AD6EQ30605561-42DE2E12-2DFE-42D0-95A7-9DA8B11439FFQ33832704-D062A68E-CE39-4648-9610-AC01A9311401Q34503147-49751FE0-E4A8-4DE7-9ADE-07D065E43F86Q35082329-9851C970-2908-44E9-84A5-22F7B7875C28Q35778704-C633952E-9546-4AC9-B714-1B3C5C272B1BQ36232627-CE7CFDEA-320F-497B-9B38-B2C1E9DA3BD4Q36284015-47BC85B9-6F93-46BD-97E4-1CD7BA1C2649Q36327838-E491E3D9-BC64-47C0-900E-705E36B04080Q36914773-CF8E7706-3CDF-460A-95C3-BA860F4697FEQ37540412-C52A2854-70D3-4D04-881E-D9046BA92B7AQ37609642-0F2C637A-D1C1-445B-85DB-B1FD4068A66DQ37783830-54450F83-AF58-4CCD-BF92-879E05FBD9FBQ40466434-B36FAD40-4346-4DB4-BC8E-CCCD3129A856Q40498654-6548E65D-C8BE-4810-B82C-F302F49C30F0Q40664212-29093F9C-9D9F-4351-9DFD-ABC047737A55Q41194711-3EA055E3-3AF6-4B10-9F63-2B1DABA9C83FQ41946111-866F3FD9-DAC8-403D-8955-408A56289962Q41984395-BCC85396-0AAE-4D13-8922-659DB992DA6BQ42032233-D038FADC-3BA4-421E-AF57-9CCF7F9D8E1CQ55059801-86BC42D0-E21D-41D3-9475-31CF23E72215
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Glutamate and epilepsy
@ast
Glutamate and epilepsy
@en
Glutamate and epilepsy
@nl
type
label
Glutamate and epilepsy
@ast
Glutamate and epilepsy
@en
Glutamate and epilepsy
@nl
prefLabel
Glutamate and epilepsy
@ast
Glutamate and epilepsy
@en
Glutamate and epilepsy
@nl
P356
P1433
P1476
Glutamate and epilepsy
@en
P2093
A G Chapman
P304
P356
10.1093/JN/130.4.1043S
P407
P433
P577
2000-04-01T00:00:00Z